Trends in incidence, therapy and outcome of localized nodal and extranodal marginal zone lymphomas: declining incidence and inferior outcome for gastrointestinal sites

References

• Thieblemont C. Clinical presentation and management of marginal zone lymphomas. Hematology Am Soc Hematol Educ Program 2005;307–313.
   PubMedGoogle Scholar
• Luminari S, Cesaretti M, Rashid I, et al. Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy. Hematol Oncol 2007;25:189–197.
   PubMed Web of Science ®Google Scholar
• Luminari S, Cesaretti M, Marcheselli L, et al. Decreasing incidence of gastric MALT lymphomas in the era of anti-Helicobacter pylori interventions: results from a population-based study on extranodal marginal zone lymphomas. Ann Oncol 2010;21:855–859.
   PubMed Web of Science ®Google Scholar
• Campo E, Swerdlow SH, Harris NL et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 2011;117:5019–5032.
   PubMed Web of Science ®Google Scholar
• Mazloom A, Medeiros LJ, McLaughlin PW, et al. Marginal zone lymphomas: factors that affect the final outcome. Cancer 2010;116:4291–4298.
   PubMed Web of Science ®Google Scholar
• Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361–13692.
   PubMed Web of Science ®Google Scholar
• Nathwani BN, Anderson JR, Armitage JO, et al. Marginal zone B-cell lymphoma: a clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1999;17:2486–2492.
   Google Scholar
• Kuper-Hommel MJ, van Krieken JH. Molecular pathogenesis and histologic and clinical features of extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue type. Leuk Lymphoma 2012;53:1032–1045.
   PubMed Web of Science ®Google Scholar
• Isaacson PG. Update on MALT lymphomas. Best Pract Res Clin Haematol 2005;18:57–68.
   PubMed Web of Science ®Google Scholar
• Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, et al. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175–1176.
   PubMed Web of Science ®Google Scholar
• Zucca E, Bertoni F, Roggero E, et al. Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med 1998;338:804–810.
   PubMed Web of Science ®Google Scholar
• Capelle LG, de Vries AC, Looman CW, et al. Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study. Eur J Cancer 2008;44:2470–2476.
   PubMed Web of Science ®Google Scholar
• Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575–577.
   PubMed Web of Science ®Google Scholar
• Wotherspoon AC, Doglioni C, De Boni M, et al. Antibiotic treatment for low-grade gastric MALT lymphoma. Lancet 1994;343:1503.
   PubMed Web of Science ®Google Scholar
• Roggero E, Zucca E, Pinotti G, et al. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 1995;122:767–769.
   PubMed Web of Science ®Google Scholar
• Bayerdorffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 1995;345:1591–1594.
   PubMed Web of Science ®Google Scholar
• Available from: www.iknl.nl
   Google Scholar
• Available from: www.palga.nl
   Google Scholar
• Percy CL, Holten VV, Muir CS. International classification of diseases for oncology. Geneva: World Health Organization; 1990.
   Google Scholar
• Fritz AG. International classification of diseases for oncology ICD-O3. Geneva: World Health Organization; 2000.
   Google Scholar
• van de Schans SA, Issa DE, Visser O, et al. Diverging trends in incidence and mortality, and improved survival of non-Hodgkin's lymphoma, in the Netherlands, 1989-2007. Ann Oncol 2011;23: 171–182.
   PubMed Web of Science ®Google Scholar
• Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006;107:265–276.
   PubMed Web of Science ®Google Scholar
• Sant M, Allemani C, Tereanu C, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 2010;116:3724–3734.
   PubMed Web of Science ®Google Scholar
• Wotherspoon AC. Gastric MALT lymphoma and Helicobacter pylori. Yale J Biol Med 1996;69:61–68.
   PubMed Web of Science ®Google Scholar
• Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1267–1271.
   PubMed Web of Science ®Google Scholar
• Roosendaal R, Kuipers EJ, Buitenwerf J, et al. Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol 1997;92:1480–1482.
   PubMed Web of Science ®Google Scholar
• Loffeld RJ, van der Putten AB. Changes in prevalence of Helicobacter pylori infection in two groups of patients undergoing endoscopy and living in the same region in the Netherlands. Scand J Gastroenterol 2003;38:938–941.
   PubMed Web of Science ®Google Scholar
• Liu H, Ye H, Ruskone-Fourmestraux A, et al. t(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002;122:1286–1294.
   PubMed Web of Science ®Google Scholar
• Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, et al. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 2001;357:39–40.
   PubMed Web of Science ®Google Scholar
• Available from: www.hovon.nl/werkgroepen/studiewerkgroepen/lymfomen/richtlijnen-lymfomen/dlbcl.html
   Google Scholar
• Available from: www.nccn.org/professionals/physician_gls/pdf/nhl.pdf
   Google Scholar
• Janssen-Heijnen ML, van Spronsen DJ, Lemmens VE, et al. A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma: prognostic impact independent of International Prognostic Index. Br J Haematol 2005;129:597–606.
   PubMed Web of Science ®Google Scholar
• van Spronsen DJ, Janssen-Heijnen ML, Lemmens VE, et al. Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry. Eur J Cancer 2005;41:1051–1057.
   PubMed Web of Science ®Google Scholar
• Thieblemont C, Bastion Y, Berger F, et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol 1997;15:1624–1630.
   PubMed Web of Science ®Google Scholar